Johnson & Johnson’s (J&J’s) arm Janssen’s Covid-19 vaccine has received permission for imports, while its local partner Biological E has got approval to start manufacturing the vaccine at its facility in Telangana. However, there is no clarity yet on when the vaccine would be available in India or whether the matter on indemnity has been amicably settled.
According to sources, discussions are on between J&J and the Centre on the matter of indemnity against any serious adverse effect after vaccination. The J&J single-dose vaccine is expected to be imported for ‘fill and finish’. This means that a local partner
According to sources, discussions are on between J&J and the Centre on the matter of indemnity against any serious adverse effect after vaccination. The J&J single-dose vaccine is expected to be imported for ‘fill and finish’. This means that a local partner

)